Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may downregulate OR52D1 by enhancing histone acetylation, which could disrupt the specific transcriptional activators from initiating the gene's transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inducing DNA demethylation, 5-Azacytidine could decrease OR52D1 transcription by altering the binding affinity of DNA-binding proteins to the gene's promoter, thereby reducing the initiation of transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A may hinder the expression of OR52D1 by binding to its promoter DNA sequences, obstructing the association of essential transcriptional machinery with the gene, thereby decreasing its transcriptional activity. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound could inhibit the transcription of OR52D1 by intercalating between DNA base pairs, preventing RNA polymerase from advancing along the DNA template and effectively halting the synthesis of OR52D1 mRNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin might repress OR52D1 expression by activating specific nuclear receptors that, upon activation, repress the transcription of certain genes, including OR52D1, by recruiting corepressor complexes to the promoter. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could decrease the stability of OR52D1 mRNA by disrupting intracellular trafficking and lysosomal degradation pathways, potentially leading to a reduction in the half-life of the OR52D1 mRNA transcript. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate may lead to the downregulation of OR52D1 by inhibiting histone deacetylases, which changes the chromatin landscape surrounding the OR52D1 gene to a state less conducive to transcriptional activity. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin could reduce OR52D1 protein levels by causing the premature termination of mRNA translation, leading to the production of truncated, nonfunctional proteins and a decrease in full-length OR52D1 protein synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin may inhibit the expression of OR52D1 by binding strongly to RNA polymerase II, leading to a cessation of OR52D1 mRNA production due to the inhibition of mRNA elongation during transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide might suppress OR52D1 protein production by blocking the translocation step in protein synthesis, leading to an overall reduction in the translation of OR52D1 mRNA in the cytoplasm. | ||||||